indazoles has been researched along with Parasitemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arán, VJ; Batista, DDGJ; Batista, MM; Cumella, J; da Silva, CF; de Oliveira, GM; Escario, JA; Fonseca-Berzal, C; Gómez-Barrio, A; Peres, RB; Silva da Gama Nefertiti, A; Soeiro, MNC | 1 |
| Canavese, M; Crisanti, A; Dottorini, T | 1 |
2 other study(ies) available for indazoles and Parasitemia
| Article | Year |
|---|---|
Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant
Topics: Animals; Cell Line; Chagas Disease; Drug Resistance; Drug Therapy, Combination; Humans; Indazoles; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Topics: Acute-Phase Proteins; Animals; Axitinib; Carrier Proteins; Disease Models, Animal; Drug Synergism; Imidazoles; Immune Tolerance; Indazoles; Lipopolysaccharides; Malaria, Cerebral; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Parasitemia; Plasmodium berghei; Protein Kinase Inhibitors; T-Lymphocytes, Regulatory; Vascular Endothelial Growth Factor A | 2015 |